drugset / Trial / NCT01708057
A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients
RandomizedCrossoverDouble-blindTreatment
Summary
This study in Chronic Obstructive Pulmonary Disease (COPD) patients will investigate the bronchodilatory effect of AZD8683. AZD8683 will be tested versus placebo and an active comparator.
Timeline
- Start
- 2012-10
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8683 | Unknown | 50 ug | Inhaled |
| Subject | AZD8683 | Unknown | 150 ug | Inhaled |
| Subject | AZD8683 | Unknown | 300 ug | Inhaled |
| Subject | AZD8683 | Unknown | 900 ug | Inhaled |
| Comparator | Tiotropium | Other / unclassified | 18 ug | Inhaled |